| 20 Jan, 03:23 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 20 Jan, 02:16 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding the media release in relation to the Unaudited Standalone and Consolidated financial results of the Company for the quarter and nine months ended December 31, 2025. | nse |
| 20 Jan, 02:14 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 20 Jan, 02:08 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding Corrigendum to the Media Release submitted with the Outcome of the Board Meeting dated January 20, 2026. | nse |
| 20 Jan, 01:37 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Results For Quarter And Nine Months Ended December 31, 2025 | bse |
| 20 Jan, 01:31 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on January 20, 2026. | nse |
| 16 Jan, 05:58 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding updates on acquisition | nse |
| 16 Jan, 05:57 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Updates on Acquisition | bse |
| 15 Jan, 02:45 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding Earnings Conference Call for Q3FY26 scheduled to be held on January 20, 2026 at 04:30 P.M. (IST) | nse |
| 13 Jan, 06:54 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Board Meeting Intimation for Considering And Approving The Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2025 And To Transact Other Business Matters | bse |
| 07 Jan, 06:13 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on January 07, 2026. | nse |
| 03 Jan, 08:55 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Board Meeting Intimation for Considering And Evaluating Proposals For Raising Funds By Way Of Issue Of Convertible Warrants On Preferential Basis To The Promotors/Promoter Group Including Determination Of Issue Price | bse |
| 01 Jan, 03:53 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 | bse |
| 30 Dec, 06:27 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding revised intimation in respect of earlier intimation dated December 29, 2025 under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 | nse |
| 29 Dec, 06:47 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding intimation under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 | nse |
| 22 Dec, 05:28 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange about Transcript of Business Update Call held on December 16, 2025 | nse |
| 22 Dec, 05:26 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Transcript Of Business Update Call | bse |
| 20 Dec, 02:54 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding granting of Inter Corporate Loan | nse |
| 20 Dec, 02:49 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Intimation Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 | bse |
| 18 Dec, 12:29 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 | bse |
| 16 Dec, 04:49 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding Audio Recording of Business Update Call | nse |
| 16 Dec, 04:44 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 15 Dec, 07:59 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding Business update call | nse |
| 15 Dec, 07:55 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange about Investor Presentation | nse |
| 15 Dec, 07:54 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 15 Dec, 07:48 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding Acquisition | nse |
| 15 Dec, 07:47 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Acquisition | bse |
| 11 Dec, 09:31 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 11, 2025, titled "Senores Pharmaceuticals, Inc. announces the approval and launch of Deferiprone Tablets USP, 500 mg & 1000 mg which will be marketed by Dr. Reddy s Laboratories Inc. in the US market". | nse |
| 11 Dec, 09:30 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 05 Dec, 06:09 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding Analyst/Institutional Investor meet scheduled to be held on December 11, 2025 | nse |
| 05 Dec, 03:16 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 05 Dec, 03:16 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 05, 2025, titled "Senores Pharmaceuticals receives Philippine FDA approval for 10 products". | nse |
| 05 Dec, 10:34 am | — | … | Senores Pharmaceuticals Ltd - 544319 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. | bse |
| 05 Dec, 10:33 am | — | … | Senores Pharmaceuticals Ltd - 544319 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. | bse |
| 13 Nov, 11:10 am | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding the transcript of Earnings Conference Call held on Thursday, November 06, 2025 for Q2 & H1FY26 | nse |
| 13 Nov, 11:08 am | — | … | Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 07 Nov, 11:07 am | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding copy of Newspaper publication for Unaudited Standalone and Consolidated financial results for quarter and half year ended September 30, 2025 | nse |
| 06 Nov, 07:56 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding link of Audio recording of Earnings Conference Call for quarter and half year ended September 30, 2025 | nse |
| 06 Nov, 07:55 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 06 Nov, 05:10 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding Monitoring Agency Report for the quarter ended September 30, 2025 | nse |
| 06 Nov, 05:07 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report | bse |
| 06 Nov, 03:07 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding changes in the Senior Management Personnel ("SMP") of the Company | nse |
| 06 Nov, 03:04 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 06 Nov, 02:18 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 06 Nov, 02:18 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange about Investor Presentation | nse |
| 06 Nov, 02:11 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 06 Nov, 02:11 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding a media release dated November 06, 2025, titled "Strong Financial & Operational Performance for Q2 & H1 FY26". | nse |
| 06 Nov, 02:04 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Results For Quarter And Half Year Ended September 30, 2025 | bse |
| 06 Nov, 02:00 pm | — | … | Senores Pharmaceuticals Limited has submitted to the Exchange Outcome of Board Meeting held on November 06, 2025 | nse |
| 05 Nov, 06:46 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Acquisition | bse |